This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Bavarian Nordic A/s, Venture Technologies Sdn Bhd. Active years: 2010-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 136 
2 out of 2 Years Active: 2010-2014
Title: The Innovative Work of Magdeline Sia Henry Sum in Flavivirus Vaccines
Introduction: Magdeline Sia Henry Sum is a prominent inventor based in Kuching Sarawak, Malaysia. With a focus on groundbreaking biomedical innovations, he has secured two patents that significantly contribute to the fight against Flavivirus infections, particularly dengue viruses. His dedication to advancing medical science showcases the critical role of inventors in developing effective health solutions.
Latest Patents: Magdeline's latest patents include the development of a Flavivirus NS1 subunit vaccine, which pertains to NS1 proteins or fragments of Flaviviruses, primarily targeting Dengue virus serotypes. This invention is pivotal for creating vaccinations against dengue and offers protection against various Flavivirus strains. Another noteworthy patent involves an MVA virus vector expressing dengue NS1 protein. Similar to the first, this invention aims to enhance vaccine development against dengue by leveraging the NS1 protein, facilitating a comprehensive approach to immunization across different serotypes.
Career Highlights: Throughout his career, Magdeline Sia Henry Sum has worked with reputable companies, including Bavarian Nordic A/S and Venture Technologies Sdn Bhd. His contributions in these organizations have established him as a key figure in the path towards innovative vaccine development.
Collaborations: In his professional journey, Magdeline has collaborated with esteemed colleagues like Paul Michael Howley and Sonja Leyrer. These partnerships reflect the collaborative nature of scientific research and innovation, which often relies on the combined expertise of various professionals in the field.
Conclusion: Magdeline Sia Henry Sum's work in creating vaccines against Flavivirus infections exemplifies the importance of innovation in healthcare. His contributions not only advance scientific knowledge but also improve public health through effective prevention strategies. As he continues to pursue further advancements, the impact of his inventions will resonate within the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile